Improved benzodiazepine radioreceptor assay using the MultiScreen Assay System.

Area of Science:

• Pharmacology
• Biochemistry
• Assay Development

Background:

• Benzodiazepine receptor assays are crucial for drug discovery and neuroscience research.
• Conventional filtration methods can be time-consuming and labor-intensive.
• Optimizing assay efficiency is essential for high-throughput screening.

Purpose of the Study:

• To describe an improved benzodiazepine radioreceptor assay with reduced incubation and filtration times.
• To validate the use of the MultiScreen Assay System for benzodiazepine binding assays.
• To assess the feasibility of using fluorescent labels with the developed assay.

Main Methods:

• Utilized the MultiScreen Assay System, a 96-well plate with integrated filters, for simultaneous incubation and filtration.
• Quantified bound [3H]flunitrazepam using filter punching after filtration.
• Investigated ligand-receptor dissociation using Tris-HCl buffer and flumazenil for fluorescent label compatibility.

Main Results:

• The MultiScreen Assay System yielded results comparable to conventional filtration manifolds (e.g., lorazepam Ki values: 2.4 ± 0.30 nM vs. 1.9 ± 0.15 nM).
• The dissociation method for fluorescent labels demonstrated consistent Ki values for lorazepam (2.5 ± 0.04 nM).
• The improved assay significantly reduced overall assay time.

Conclusions:

• The MultiScreen Assay System offers an efficient and reliable alternative for benzodiazepine radioreceptor assays.
• The developed method is adaptable for both radioactive and potentially fluorescently labeled ligands.
• This optimized assay facilitates faster and more efficient screening of benzodiazepine receptor ligands.